RxDoctor Payments Data

Natalie Felter, NP

Nurse Practitioner · Sandusky, OHNPI 1184075087

Payments from drug & device makers

$1,741in general payments, 2019–2025

Across 72 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$314
  • Sun Pharmaceutical Industries Inc.$245
  • AbbVie$175
  • Lilly USA, LLC$137
  • Pfizer$115
  • Sanofi$103
  • plus $653 from 14 others

What the payments were for

  • Food & beverage$1,39980%
  • Education$34320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,741 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$155,532
Medicare patients
900
Services billed
3,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab25$176,629
Cosentyx Unoready PenSecukinumab13$135,198
OtezlaApremilast21$100,111
Dupixent PenDupilumab16$68,568
OpzeluraRuxolitinib Phosphate11$22,057
VtamaTapinarof11$14,806
Fluocinonide113$4,365
Tacrolimus26$2,312
Triamcinolone Acetonide199$2,156
Metronidazole27$2,106
Minocycline Hcl114$1,696
Fluorouracil26$1,645
Ketoconazole111$1,469
Clindamycin Phosphate22$953
Clobetasol Propionate20$858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$56$100,11121 claims
Incyte CorporationOpzelura$88$22,05711 claims
Dermavant Sciences, Inc.Vtama$26$14,80611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →